Order Article Reprints

Vasseur D, Sassi H, Bayle A, Tagliamento M, Besse B, Marzac C, Arbab A, Auger N, Cotteret S, Aldea M, et al. Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test. Cells. 2022; 11(12):1901. https://doi.org/10.3390/cells11121901

Vasseur, Damien, Hela Sassi, Arnaud Bayle, Marco Tagliamento, Benjamin Besse, Christophe Marzac, Ahmadreza Arbab, Nathalie Auger, Sophie Cotteret, Mihaela Aldea, and et al. 2022. "Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test" Cells 11, no. 12: 1901. https://doi.org/10.3390/cells11121901

Vasseur, D., Sassi, H., Bayle, A., Tagliamento, M., Besse, B., Marzac, C., Arbab, A., Auger, N., Cotteret, S., Aldea, M., Blanc-Durand, F., Géraud, A., Gazzah, A., Loriot, Y., Hollebecque, A., Martín-Romano, P., Ngo-Camus, M., Nicotra, C., Ponce, S., ... Lacroix, L. (2022). Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test. Cells, 11(12), 1901. https://doi.org/10.3390/cells11121901